Limes Schlosskliniken AG: LIMES Schlosskliniken acquires Schlossklinik Abtsee in Berchtesgadener Land/Group development QI
|
EQS-Ad-hoc: Limes Schlosskliniken AG / Key word(s): Expansion/Quarterly / Interim Statement DGAP-Adhoc: Limes Schlosskliniken AG: LIMES Schlosskliniken acquires Schlossklinik Abtsee in Berchtesgadener Land / Group development QI Cologne, May 03, 2023 - LIMES Schlosskliniken AG today acquired the property of Schlossklinik Abtsee from Bergman Deutsche Klinik Laufen GmbH. The previous clinic operation as a vein center with plastic surgery will no longer be continued. LIMES Schlossklinik will renovate the property over the next few months to meet its requirements and reopen in spring 2024 as a psychiatric clinic with approximately 50 treatment beds. The clinic is located with a spacious park at the Abtdorfer See and offers all patient rooms a unique view of the Berchtesgaden mountains. The Mozart city Salzburg with international airport is 21km away. The LIMES Group's existing clinic operations performed better than planned in the first quarter of 2023, with sales up 26%. The positive development was supported by very good clinic occupancy at the Paracelsus Klinik in Zurich. Despite the as yet uncompensated delay costs for the start-up of the new clinic in Lindlar in the amount of 243 kEUR for the first quarter, and double-digit inflation-related additional costs, the LIMES group achieved an operating result (EBITDA) of 1.340 kEUR (p.y.: 1.323 kEUR). The quarterly earnings before interest and taxes (EBIT) amount to 818 kEUR (p. y.: 808 kEUR).
Brief profile: The LIMES Schlosskliniken Group operates high-quality private clinics for stress-related illnesses, mental and emotional disorders, such as depression, affective disorders and acute burnout conditions. The range of services is aimed at private patients, those entitled to subsidies and self-payers. The LIMES Schlosskliniken Group stands for the special approach of a relationship-oriented medicine in the treatment of people with mental illnesses. In addition to top medical quality, patients are offered a unique, protected and healing environment in which they can recover holistically. Further information is available at www.limes-schlosskliniken.de. Your contact person: End of Inside Information
03-May-2023 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | Limes Schlosskliniken AG |
| Kaiser-Wilhelm-Ring 26 | |
| 50672 Köln | |
| Germany | |
| ISIN: | DE000A0JDBC7 |
| WKN: | A0JDBC |
| Listed: | Regulated Unofficial Market in Dusseldorf |
| EQS News ID: | 1623285 |
| End of Announcement | EQS News Service |
|
|
1623285 03-May-2023 CET/CEST
P R O D U C T S U G G E S T I O N S
The information presented here has been provided by our content partner EQS-Group. The originator of the news is the respective issuer, the company relating to the news, a publication service provider (press or information agency) which uses the distribution service of EQS to transmit company news to shareholders, investors, investors or interested parties. The original publications and other company-relevant information can be found at eqs-news.com.
The information you can access does not constitute investment advice. The presentation of our cooperation partners, where the implementation of investment decisions would be possible depending on the individual risk profile, is solely at the discretion of the person using the service. We only present companies of which we are convinced that the range of services and customer service will satisfy discerning investors.
If you are considering leverage products, familiarise yourself with the typical characteristics of the financial instruments beforehand. Take the time to determine the risk content of the planned investment before making an investment decision. Bear in mind that a total loss cannot be ruled out with leverage products.
For newcomers to the subject, we offer various options in both the training and the tools section, through which you can train theoretical knowledge and practical experience and thus improve your skills. The offer ranges from participation in webinars to personal mentoring. The range is continuously being expanded.
1 Lab features are usually functionalities that emerge from the think tank of the investor community. In the early stages, these are experimental functionalities whose development process is largely determined by use and the resulting feedback from the community. When integrating external services or functionalities, the functionality can only be guaranteed to the extent that the individual process elements, such as interfaces, interact with each other.